• Epi 2 with Dr. Janani Rangaswami

  • Jun 25 2024
  • Duración: 38 m
  • Podcast

Epi 2 with Dr. Janani Rangaswami

  • Resumen

  • In this episode, Dr. Rangaswami discusses "renalism" - the systematic exclusion of patients with advanced chronic kidney disease (CKD) from heart failure trials and treatments. She explains the historical reasons behind this exclusion, recent positive trends in including more CKD patients in trials, and the challenges in enrolling these patients. Dr. Rangaswami highlights the importance of representing CKD patients in research and clinical practice, noting recent developments like new risk calculators that incorporate kidney function. She also provides practical insights on using guideline-directed medical therapies in patients with advanced CKD and heart failure, including the use of newer medications and potassium binders.

    Más Menos

Lo que los oyentes dicen sobre Epi 2 with Dr. Janani Rangaswami

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.